Search Thermo Fisher Scientific
B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]).
AI593864; B4galnt2; B4GALT; beta 1,4 N-acetylgalactosaminyltransferase/betal,4 GalNAcT/Sda-GalNAcT; beta-1,4 N-acetylgalactosaminyltransferase 2; beta-1,4-N-acetyl-galactosaminyl transferase 2; beta-1,4-N-acetyl-galactosaminyltransferase 2; beta-4-N-acetylgalactosaminyltransferase; CT-Gal NAc transferase; Dlb1; Dlb-1; dolichos lectin binding 1; Galg2; Galgt2; Ggm3; Igf2bp1; N-acetylgalactosaminyltransferase; sd(a) beta-1,4-GalNAc transferase; sda beta-1,4-GalNAc transferase; UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase; UDP-GalNAc:Neu5Acalpha2-3Galbeta-R beta1,4-N-acetylgalactosaminyltransferase; UDP-N-acetyl-alpha-D-galactosamine:(N-acetylneuraminyl)-galactosyl-N-acetylglucosaminylpolypeptide-beta-1, 4-N-acetylgalactosaminyltransferase
100 µL
100 µL
100 µL